FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions relates to medicine and deals with a crystalloid cardioplegic solution, which contains salt solution, including sodium chloride, potassium chloride, magnesium chloride, calcium chloride, sodium hydrogen carbonate, water for injections and a structural analogue of natural apelin X-Arg(NGY)-Pro-Arg-Leu-Ser-His-Lys-Cly-Pro-Nle-Pro-Phe-Z, where X=CH3, Y=H, Z=OH. The group of inventions also deals with the crystalloid cardioplegic solution, containing salt solution, including sodium chloride, potassium chloride, magnesium chloride, calcium chloride, sodium hydrogen carbonate, water for injections and structural analogue of natural apelin X-Arg(NGY)-Pro-Arg-Leu-Ser-His-Lys-Cly-Pro-Nle-Pro-Phe-Z, where X=H, Y=NO2, Z=NH2.
EFFECT: group of inventions provides the recovery of the coronary flow, cardiac contractile and pump function in case of the reperfusion and the reduction of injury to membranes of cardiomyocytes.
2 cl, 2 dwg, 8 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
DODECAPEPTIDES HAVING CARDIOPROTECTIVE PROPERTIES | 2010 |
|
RU2457216C1 |
IMPROVING THE RECOVERY FUNCTION OF THE CARDIOVASCULAR SYSTEM IN ISCHEMIA TETRADECAPEPTIDES | 2017 |
|
RU2648846C1 |
CRYSTALLOID CARDIOPLEGIC SOLUTION | 2009 |
|
RU2423135C2 |
"INFUSOL" CARDIOPLEGIC SOLUTION | 2002 |
|
RU2226093C1 |
METHOD FOR CARDIOPLEGIC ARREST (VERSIONS) | 2015 |
|
RU2571058C1 |
CARDIOPLEGIA AGENT (VERSIONS) | 2014 |
|
RU2568911C1 |
WATER-SOLUBLE COMPOSITION, POSSESSIVE PROPERTIES OF CARDIO-PROTECTOR | 2010 |
|
RU2438698C1 |
METHOD OF CARDIOPLEGIC ANTEGRADE MYOCARDIAL PROTECTION | 2022 |
|
RU2803867C1 |
METHOD FOR PROTECTING MYOCARDIUM IN REPERFUSION PERIOD | 2001 |
|
RU2209602C2 |
MEANS INCREASING HEART RESISTANCE TO REPERFUSION DAMAGE | 2016 |
|
RU2642826C1 |
Authors
Dates
2015-04-27—Published
2013-11-07—Filed